HeartFlow, Inc. (NASDAQ:HTFL) highlighted as one of the AI Stocks to Watch Out For in 2025. JPMorgan initiates coverage with an Overweight rating and $36.00 price target, citing the company as a pioneering beneficiary of AI in healthcare. HeartFlow uses AI to diagnose heart disease, improving patient care and reducing costs.

JP Morgan sees HeartFlow benefiting from modern AI in healthcare, creating personalized 3D heart models to diagnose coronary artery disease. The company offers a unique diagnostic solution, leveraging AI and advanced technology to streamline workflow and lower costs. This capital-light business model has a strong gross margin profile and healthy reimbursement.

HeartFlow, Inc. (NASDAQ:HTFL) is a medical technology company at the intersection of healthcare and technology. While considered a promising investment, other AI stocks may offer greater potential. For those interested in undervalued AI stocks, a report on the best short-term AI stock is available for further information.

Read more at Yahoo Finance: AI-Enabled Heart Diagnostics Put HeartFlow (HTFL) in the Spotlight